What's the evidence for zolmitriptan?
There is good evidence that zolmitriptan can help your migraine symptoms.
We found one big summary of the evidence (known as a systematic review).1 We also found several other large, well-run studies.2 3
The review included 12 studies on zolmitriptan. The studies were all high-quality studies known as randomised controlled trials.
In some of the studies, some people took zolmitriptan and some people took a dummy treatment for comparison (called a placebo). In other studies, some people took zolmitriptan and other people took another drug for migraine called sumatriptan.
Here is a summary of what the review found about zolmitriptan.1
- Zolmitriptan relieved migraine headaches within two hours.
- Symptoms became milder or the pain disappeared completely.
- More than 6 in 10 people who took the drug felt better, while about 3 in 10 people taking a placebo improved.
- Doses of 2.5 milligrams and 5 milligrams seemed to work equally well.
- Zolmitriptan worked about as well as sumatriptan.
One big summary of the research (a systematic review) looked at all the triptan drugs available at the time (in 2007). It looked at 221 studies in total and selected 38 good-quality studies. The researchers said all triptans worked better than a dummy drug (a placebo) to reduce pain or get rid of migraine within two hours. But only sumatriptan and rizatriptan worked better than a placebo drug within half an hour.4
For more details:Read this information about the treatment in Clinical Evidence
Sources for the information on this page:
- Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002; 22: 633-658.[PubMed]
- Sakai F, Iwata M, Tashiro K, et al. Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study. Cephalalgia. 2002; 22: 376-383.[PubMed]
- Dowson AJ, MacGregor EA, Purdy RA, et al. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia. 2002; 22: 101-106.[PubMed]
- Pascual J, Mateos V, Roig C et al. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007; 47: 1152-1168.[PubMed]


